SOURCE: IMA World Health

February 23, 2010 09:29 ET

IMA World Health Receives BD Donation of 1.2 Million Syringes for Democratic Republic of Congo

NEW WINDSOR, MD--(Marketwire - February 23, 2010) - IMA World Health (IMA) today announced that BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, has donated and shipped 1.2 million vaccination syringes to IMA's comprehensive health projects in the Democratic Republic of Congo. BD also donated and shipped 1.7 million vaccination syringes in 2008.

The 1.2 million disposable, one-use syringes shipped from BD's European facilities to the Democratic Republic of Congo primarily are used for measles and DPT vaccines. DPT is a combination vaccine against three infectious diseases: diphtheria, pertussis (whooping cough) and tetanus. The vaccines are prioritized for infants under age five months.

The syringes are being distributed through the AXXES project, an IMA-led consortium of faith-based partners providing maternal and child health to a population of 8.2 million. AXXES is funded by the United States Agency for International Development (USAID).

"BD's generous donation of syringes will enable critical vaccination programs in the Democratic Republic of Congo to continue," said Richard Santos, President and CEO of IMA. "Due to the economic crisis, supplies such as syringes have been more difficult to obtain, placing thousands of people at risk, especially children. BD's timely generosity is literally life-saving."

Before civil war broke out in the Democratic Republic of Congo, the nation's leaders designed a plan to divide the country into health zones. Each health zone had hospitals and clinics staffed with trained health personnel to care for the people living in their zones. During the civil war, these hospitals and clinics were looted and destroyed. With the return of peace, IMA World Health entered into a joint project to rebuild the health zones. That work began in 2000; currently the program delivers basic health care services, including vaccinations, to approximately 10 million people in more than 60 health zones.

"IMA is serving the critical need of the DRC by increasing vaccination rates in children under five for diseases including tetanus and measles. By delivering these vaccines, IMA's work is a tremendous contributor to protecting the health of these children," said William Kozy, BD Executive Vice President.

About IMA World Health

IMA World Health is a 501(c)(3) nonprofit organization that helps provide essential healthcare services and medical supplies to people in need around the world. IMA operates primarily in developing nations to restore health, hope and dignity to those most in need. For more information, visit us at www.IMAWorldHealth.org or call 877-241-7952.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact Information

  • Media Contacts:
    John Jordan
    Principor Communications (for IMA)
    (202) 595-9008 x63
    Email Contact